Medicine Man Technologies (MDCL)

Medicine Man Technologies (MDCL)

Medicine Man Technologies (MDCL) is offers counseling and administrations services for the development, creation, and dispensary operations. At present serving 25 customers in 13 states and also having effectively upheld permit applications (development and dispensary) in Illinois and in addition Nevada.

Make sure you check out our marijuana stocks page.

The company has recently announced to issue $12.6mm in Stock in order to Buy Pono Publications and Success Nutrients. These acquisitions are likely to bolster its sales and product portfolio. Its outstanding shares are standing around 10,092,500, while authorized shares are at 90,000,000.

The Pono Publications Inc. brand incorporates the Three A Light cultivation publication with an ‘Expert Grade’ adaptation being produced solely for both Three A Light and Medicine Man Technologies customers. This new development convention has as of now accomplished yields in the 450-gram per square foot range and is deployable in both nursery and indoor based facilities.

Notwithstanding having a counseling customer in Las Vegas, since January of this current year, Pono Publications has sold in abundance of 800 of the Three A Light manuals.
The Success Nutrients brand provides one of the key underpinnings of the cultivation methodology and is essential to the overall Three A LightTM performance metric. With an investment of two years of research, development and intense testing, this product line was specifically formulated for the cannabis industry.

Within nine months of operations, this new start up business has already achieved strong growth, most recently generating $100,000 in sales in July (up from 1st month sales of $4,000 in December 2015). While there can be no assurances of future growth given at this time, recent inquiries suggest this company will be growing considerably in the upcoming year. Keep in mind there are always risk involved when you invest in penny stocks.

The Success Nutrients brand gives one of the key underpinnings of the development philosophy and is fundamental to the general Three A LightTM execution metric. With a venture of two years of examination, improvement and exceptional testing, this product offering was particularly figured for the cannabis business.

What are marijuana stocks and why invest?

 

Washington, Colorado, Alaska, and Oregon have legitimized the utilization of Marijuana. Overall, Twenty-three states altogether have made the medication lawful for restorative use. This generally new legitimization has permitted many new organizations that have some expertise in the plant to rise. Some of those organizations have opened up to the world and offer another venture specialty: pot stocks.

Any item you can envision has a traded on an open market organization behind it. Soda pops have COKE (COKE) and Pepsi (PEP), beer has Anheuser-Busch (BUD) and Molson Coors (TAP), and tobacco has Phillips Morris (PM) and so forth. Since it is legitimate in numerous regions around the nation, Marijuana additionally has organizations that spend significant time on developing marijuana. At the point when those organizations issue stock, they are considered marijuana stocks.

Cultivators are only one sub-area of this industry. These organizations spend significant time in developing the plants, and subsequent to the gathering, they offer them to merchants who are then in charge of everything else down the line. Be that as it may, those are not by any means the only organizations that represent considerable authority in weed stocks. There are likewise pharmaceutical organizations like Vancouver-based Abattis Bioceuticals Corp and London-based GW Pharmaceuticals (GWPH).

How are Cannabis Stocks Valued?

Keeping in mind the end goal to better comprehend pot stocks’ valuation, we have to know a tad bit about how all stocks are esteemed.

At the point when an organization arrangements to open up to the world about their stock, they will procure a financier. These guarantors, typically colossal venture banks like Goldman Sachs, dissect the organization to decide its value. Starting there, the guarantor will work with the organization administrators to decide a stock price.

Why put resources into pot penny stocks?

You may as of now have a few explanations behind needing to put resources into marijuana stocks, however as a refresher, here are some enormous reasons why speculators are warming up to the pot market. Most of these stocks are still penny stocks.

  • 4 states have endorsed recreational marijuana laws.
  • 24 states have endorsed medicinal marijuana laws.
  • The legitimate marijuana market grew 17% in 2015 to $5.4 billion, as indicated by ArcView Market Research.
  • ArcView gauges the business sector will develop another 25% in 2016 to $6.7 billion.
  • After recreational pot laws went in 2012, Colorado’s weed deals have as of now hit $1 billion every year.
  • And, research into marijuana based pharmaceutical proposes it could offer new would like to individuals experiencing destroying infections, for example, epilepsy.

The weed business sector is extending rapidly as states pass expert pot enactment. Be that as it may, offers of marijuana could truly take off if voters give cannabis proposition an OK in intensely populated states like California. California was at the front line of the restorative cannabis development in the mid-90s and upwards of 1,000 therapeutic weed dispensaries as of now work there.

In Conclusion

For the canny speculator, marijuana stocks can be entirely lucrative. In any case, first, you need to weed out those that are performing inadequately and make an informed supposition on which ones will even now be around and thriving as the laws are extricated. For the individuals who plan to profit from the pot business, yet would like to lessen their danger, there are many ventures identified with the pot business, however, have comes to long ways past.  Marijuana stocks right now happen to be some of the hottest penny stocks investors are putting their money in.

Cronos Group TSX:CRON

Cronos Group CRON

Cronos is an innovative global cannabinoid company based in Toronto. Incorporated in 2013, the company seeks to invest in medical marijuana producing companies through its vertical integration and horizontal diversification business model. It is one of the largest cannabis companies in the world.

Company Background

Cronos Group is a global cannabinoid company based in Toronto, Canada. Incorporated in January 2013, the company seeks to invest in either licensed or actively license-seeking medical marijuana companies. Consequently, it is committed to building industry-leading cannabis companies that elevate the consumer experience through brand expansion. Cronos Group is listed on Nasdaq and the Toronto Stock Exchange (TSX) under the ticker symbol “CRON.”

Cronos Group’s business model is based on vertical integration and horizontal diversification. The company primarily serves Canadian consumers through its two wholly-owned subsidiaries: Peace Naturals and Origin BC Ltd. Nevertheless, Cronos has been able to expand its production and distribution operations to many countries across five continents — prominently to Australia and Israel. The company continues to pursue an iconic international brand recognition through the expansion of its global operations.

Cronos Group’s mission is to improve people’s lives by unlocking the full potential of cannabis. Also, it is driven by the vision to transform industries through cannabinoid innovation. The company’s ever-increasing global network through partnerships and joint ventures portends that its mission and vision are easily achievable.

Industry Overview

Currently, the global cannabis industry is the fastest-growing industry in the world. In fact, analysts at the investment firm, Cowen, project that the global cannabis industry could generate as much as $75 billion by 2030. Interestingly, the industry recorded in global sales $6.9 billion in 2016, a figure which significantly increased to $9.5 billion and $12.2 billion in 2017 and 2018 respectively.

For the global cannabis industry, the impressive run from 2016 through 2017 and 2018 was not enough. The industry is seriously poised for sustainable and rapid growth. Little wonder analysts estimate that the figures would further be racked up for 2019. At the projected global revenue yearly increase of approximately 39%, global cannabis sales can easily hit $16.9 billion and $31.3 billion by 2019 and 2022 respectively.

Moreover, it is becoming increasingly easier to engage in the cannabis business. Recreational cannabis consumption has become legal in nine American states, while medical use is already okayed in 33. In a bid to control its illegal use, in October 2018, the Canadian government passed a bill fully legalizing the recreational use of cannabis for adults. Add to these the fact that for the cannabis business, the European market is still green. In fact, Germany depends solely on imported cannabis products to meet its local needs.

According to a report by the Canadian Business Executive, there are seven key factors that contribute to the success of any cannabis company. These include financing, corporate structuring, strategic partnerships, product diversity and differentiation, branding, marketing, and distribution. Therefore, with a business model centered around these factors, any cannabis company should be able to have prosperous runs. Let us see how Cronos has been faring on some of those.

Cronos: Strategic Deals Could Help Expand Production Capacity

Cronos Group primarily operates as a joint venture comprising Peace Naturals, Original BC, Cronos Israel, and Cronos Australia. Currently, all these facilities produce approximately 120,000 kilograms in peak annual yield. Still, this production capacity does not compare well with Cronos market capitalization, being one of the highest in the industry. Therefore, pushing to expand its production capacity has been one of its goals.

Another challenge that Cronos has been planning ahead for is the potential problem of domestic oversupply of cannabis. This, however, is not peculiar to Cronos: its peers too will be affected in any situation of such. Therefore, to prevent this, Cronos has been seeking to expand to international markets. Interestingly, the company has taken steps to boost production capacity and hedge against the risk of domestic oversupply.

Moreover, it is important to note that Cronos’ strategy to focus on alternative cannabis products with higher margins is an impressive one and should contribute to its profitability. In September 2018, it announced it would be entering into a partnership with Gingko Bioworks. The deal, valued at almost $100 million, would enable Cronos to use Gingko’s proprietary organism design technology. The technology, used to produce special yeast strains, can be applied to the production of improved cannabinoid.

The deal demonstrated Cronos’ commitment to increase its products base to more of alternative cannabis products. The novel technology, being more efficient than traditional techniques, will boost its alternative cannabis products manufacturing capacities, and subsequently its long-term operating margin.

The Gingko’s deal was followed, in December, with the strategic alliance made with Altria, one of the largest producers and distributors of cigarettes and allied products in the world. The tobacco company presumably seeks to work with Cronos on cannabis vape sometimes in the future.

Altria invested $1.8 billion in Cronos to gain control of a 45% equity stake in it. Plus warrants, the deal could shore up Altria’s stake to as much as 55%. The finalization of the deal and the issuing of more shares mean that Cronos would be $1.8 billion richer. These two deals have had a significant impact on Cronos “CRON,” to the extent that it rallied by more than 90% in January 2019 alone.

Financials Reveal Operating Losses

For the first quarter of 2019, Cronos’ net sales increased to $4.81 million, representing 120% year over year increase over the first quarter of 2018. Nevertheless, the company actually sustained a loss on an operating basis as the seemingly stellar revenues were due to one-time gains.

In February 2018, Cronos became the first marijuana company to uplist from the over-the-counter market to Nasdaq. The step confirmed its viability as a business helped boost the liquidity of its shares, and also enhanced its access to institutional investment. However, with its market capitalization of approximately $5 billion and a forward price-to-earnings ratio of almost 470 Cronos (CRON) might be overvalued. Currently, though, it has an estimated P/E ratio of 54.5×.

Summary

Cronos makes a good long-term investment. Generally, the cannabis industry has just started; it is no hype. And its members are expected to benefit from its growth. All the same, depending on the efforts of each, the benefits may not be equal. Cronos is poised to do great things. It surely makes a good long-term investment. However, it first has to improve its international market presence, manage its expenses, and control its operating losses.

 

 

Which Canadian marijuana stocks are the best to buy? Come vote for the one you like.

Which Canadian Cannabis stocks are the best to buy?

Marijuana stocks have been one of the most talked about sectors since Canada made recreational use legal last year.  Many analyst are predicting that the marijuana industry could grow to 50-130 billion in revenue by 2030. These analyst believe it could become a bigger market than the Alcohol beverages market which currently takes up 16.5% of the US beverage market. I believe some of these estimates are very optimistic and some may be unrealistic, even though the Global Alcohol beverage market has slower growth and a CAGR of just over 3% compared to the marijuana market which is around 25% CAGR. Regardless of how bullish you are with the estimates almost everyone can agree that the Cannabis market still is looking at huge growth over the next ten years.

Short Summary of the top Cannabis stocks

I am not here to tell you which stock you should buy or which company you should invest in. What I will do is provide short summaries based on recent events with the company so you can make your own decisions.

CGC – Canopy Growth – TSX: WEED

Canopy Growth as of 05/09/2019 is currently at 46.90 a share and has a current market cap of 16.26 Billion. They have 344.14 million shares outstanding.  The average volume over the last 10 days is 6.6 million. They have an EPS of -2.01 and a revenue per employee of $115,040. The company CEO is Bruce Linton. Over 144,000 Robinhood users currently have shares of the stock.

Canopy made a huge splash last year when Constellation the company that makes the beer Corona bought 38% of the company. At the time they spent billions to buy shares of Canopy at an average premium of over 51% of the market value at the time. This acquisition brought a lot of attention to the entire Cannabis Sector.

In recent news Canopy has signed a condition agreement with Acreage Holdings a US based marijuana company. This agreement will allow CGC to make a quick transition to the American market if/when Cannabis is legalized on a federal level. CGC also has recently acquired C3 the German based Cannabinoid Compound company. This acquisition allows them to have access to the medical marijuana market with the product Dronabinol. Canopy has been very active in establishing new brands and making new supply agreements.

HEXO – Hexo Corp. TSX: Hexo

Hexo is currently at $7.37 a share and has a current market cap of 1.58 billion.  They have 210.61 million Outstanding shares. The average volume over the last 10 days has been 4.12 million shares traded. It’s current EPS is at -0.11.  The CEO is Sebastien St. Louis. Currently over 118,000 Robinhood user own shares of it.

Hexo has received an agreement to supply a large amount of marijuana in Quebec which is the second most populated providence in Quebec. Hexo market share in Quebec is currently just under 40% which is a significant amount of market share. Last year Hexo announced a joint agreement with Molson Coors Brewing company to develop  Cannabis-infused beverages. Hexo acquired Newstrike Brands which gives them almost 500,000 square feet of production capacity. Hexo specializing in CBD and a lot of investors are drawn to its lower market cap.

TLRY- Tilray Inc.

TLRY is currently at 46.40 a share with a current market cap of 4.46 Billion. They currently have 80.13 million shares outstanding.  They have an EPS of -.073 and have revenue of $62,690 per employee. Brendan Kennedy is the CEO. just over 35,000 users of Robinhood own shares of it.

TLRY just announced this week it plans to spend 32.6 million to add an addition 200,000 sq. ft to three facilities. The company now has almost 1.4 million Sq Ft for its product and manufacturing world wide. TLRY is one of the few cannabis stocks that is down for the year largely due to insider selling. Privateer Holdings which owns the majority of TLRY decided not to sell their shares when the lockout ended earlier this year. At the time the stock was at nearly $100 a share. TLRY has yet to get a big deal like CRON and CGC. Given most of the float being locked up it is very possible there could be a price increase before Privateer Holdings sells their shares.

CRON – Cronos Group INC.

CRON has a current share price of 14.10 a share.  It’s market cap is 2.75 Billion and has an EPS of -0.08. It’s average Revenue per Employee is at $19,100. The CEO is Michael Gorenstein. It has roughly 187,000 users of Robinhood that own shares in it.

CRON received 1.8 billion from Altria Group. that equity investment at the end of last year brought a lot of attention to Cronos and the stock price went up significantly.  Altria has a lot of resources at their disposal which could mean they could help a lot with the growth and expansion. CRON reported a 120% increase in year over year revenue the first Quarter. Cronos stock price is coming back down to earth and may be a good one to watch soon.

ACB – Aurora Cannabis Inc.

ACB is currently at $8.38 a share. It has a market cap of 8.7 billion and currently has 1.01 billion shares outstanding. Its EPS is -0.02 and its revenue per employee is $94,400. Nearly 440,000 Robinhood users own shares of ACB.

ACB focuses on both the recreational and the medical marijuana market. They just hired billionaire activist investor Nelson Peltz as a strategic advisor. They currently in twenty four different countries. ACB has the production capacity that allows it to outproduce all other marijuana companies.

 

Now it is your turn to vote on which marijuana stock will do the best over the next five years.

Coming Soon
Which of the follow marijuana stocks will perform the best over the next five years?
Which of the follow marijuana stocks will perform the best over the next five years?
Which of the follow marijuana stocks will perform the best over the next five years?

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3 indexes to find Marijuana Stocks To Watch

          Marijuana Stocks To Watch

There are three major markets where the marijuana stocks get traded, be it medicinal marijuana stock or recreational marijuana stock. These major markets see to the buying and selling, the investments and risk taking, the taxes, revenues, income and expenditure of marijuana. Namely: NASDAQ, NYSE and OTC (Over The Counter) trading.

NASDAQ

     NASDAQ stands for the National Association of Securities Dealers Automated Quotations, it is an electronic stock market where tradings of securities are carried out. In the aspect of marijuana stocks, NASDAQ is an electronic trading ground for both medical and recreational marijuana.

Marijuana Stocks on the NASDAQ

     While the U.S government still forbids marijuana technically, but due to the legalization and regulation of marijuana around the States and Canada, the illegal sales are reducing and legal sales are increasing. Cultivation facilities are sprouting up, retail outlets are on the move and the stocks are in supply. Due to this, marijuana products have found their way into various products like mouth-wash (Sativex for example), gels, lotions, drugs (Epidiolex). Even with all this legalization propaganda loop-holes have been found and is being used. The major loop-hole being this; Canada has legalized the sale and us of cannabis, thus Canada can sell cannabis on American Soil due to the fact of a clause which states that sales of marijuana can take effect if it is legal in the state where it is produced.

  • Cronos group became the first company to trade on the NASDAQ after trading for years in Canada and was also the first pure-play marijuana stock trader.
  • Tilray Incorporated became the second major player of marijuana stock on NASDAQ few months later, becoming the first NASDAQ to offer an Initial Public Offering (IPO).
  • Cronos group has also partnered with MedMen which is a large cultivator, grower and retailer of cannabis in California, to increase their production rate and supply chain.

All these major developments has allowed marijuana to penetrate into the U.S exchange without breaching any rules and is giving their rivals, the recreational marijuana stock a run for the market.

NYSE

The NYSE stands for New York Stock Exchange, this is the stock exchange based in New York City and controls most parts of the trading in the United States.

  • As of September, 2018, Canopy Growth became the only pure-play marijuana stocks trader on the New York Stock Exchange. Worth more than a billion dollars due a multi-billion dollar investment from Constellation Brands.
  • Aurora Cannabis a Canadian based multi-billion dollar marijuana dealer, having partnership deals with major multi-billion companies and is also the biggest production output of marijuana with over 700,000 kilograms annually.
  • Curleaf Holdings: Curaleaf holdings broke out in August, 2018, becoming the largest Initial Public Offering (IPO) marijuana stock on the NYSE boasting of its own dispensaries, cultivation facilities, supply network and processing sites.

Over The Counter

Over the counter trading deals with the trading of marijuana stocks in retail shops.

  • Green Thumb Industry operates OTC with a net worth of $1.7 billion, with over 69 retail stores in 8 different market after being given the licenses to operate.
  • Acreage Holdings operates OTC also with a net of $1.5 billion and has its own retail offices and implementation of cultivation facilities
  •   Learn the various markets that the penny stocks operate in and invest in them.

 

Tweed Inc. (Tweed), wholly owned subsidiary of Canopy Growth Corporation (Canopy Growth) (TSX: CGC) (OTC: TWMJF)

Tweed Inc. (Tweed), wholly owned subsidiary of Canopy Growth Corporation (Canopy Growth) (TSX: CGC) (OTC: TWMJF)

Tweed Inc. (Tweed), wholly owned subsidiary of Canopy Growth Corporation (Canopy Growth) (TSX: CGC) (OTC: TWMJF), launched Lemon Skunk in the Tweed store. This is the first strain bred from DNA Genetics, hand selected through painstaking phenotyping by DNA Genetics, and grown to DNA standards in Tweed’s world-class facility at One Hershey Drive in Smiths Falls, Ontario.

The dispatch of this prestigious line-up of handpicked hereditary qualities takes after a late declaration that Tweed has propelled another seed rearing zone, which will serve as a monstrous quickening agent towards exceptional item improvement capacities keeping in mind the end goal to extend quality and assortment through development.

Notwithstanding fresh out of the box new items, Tweed and DNA have worked together on a phenotyping venture that has now yielded dried cannabis deserving of authority affirmation by the California-conceived, Holland-based reproducing group.

“This coming October will check one entire year we have been working with the fantastic group at Tweed,” said Don of DNA Genetics. “We’ve been through a large number of hereditary qualities over that time, and went through numerous days with the cultivators, base and plants there at Tweed. We’re pleased to put our DNA logo and blessing on the Tweed box.”

The company recently announced strong results for the first quarter with the revenue growth 300% to $7.0 million years over year, also representing a growth of a 39% increase over fourth quarter of last year.

Its shares are currently trading around $2.94 a share with a market capitalization of 321 million. The company’s stock has 52 week range of $1.140 – $3.229 a share. Its daily average share volume stands s around 33,804 shares. The company’s outstanding shares around 107.43 million while authorized share are at 305.91 million.

The Future of the Marijuana Industry

The Future of the Marijuana Industry

Marijuana is at present classified by the U.S. Drug Enforcement Administration (DEA) as a Schedule I confined medication, the most firmly limited classification. That implies the DEA considers marijuana, together with heroin, LSD and other personality adjusting substances, a medication with no at present acknowledged restorative utilization and high potential for misuse.

In spite of this mark, four states have now authorized marijuana for recreational use, and 23 states altogether have authorized it for medicinal use. Surveys by the Pew Research Center have reported that Americans for the most part support legitimization the nation over, and late studies on the impacts of authorization in Colorado and Washington State have reinforced the case for government sanctioning.

Moreover, on the medicinal front, thinks about have demonstrated that marijuana can be utilized to treat a large group of mental and physical sicknesses. In spite of this, the pot business still faces numerous obstacles before it can achieve full legitimization.

The legalization of marijuana has profited Colorado both financially and socially. Official insights demonstrate that the state gathered $23.7 million from charges, licenses and expenses year-to-date for FY 2015-2016, an expansion of 70 percent ($13.9 million) from the earlier monetary year.

In Washington state, one year after the authorization of recreational maryjane, deals have been averaging $2.4 million a day in August. This means expected revenue of $65 million in FY 2016 for Washington state).

Be that as it may, Colorado and Washington have not quite recently profit by gathering taxes. since the death of Washington Initiative 502 on the November 2012 general vote, Washington has seen its savage wrongdoing rates diminish, while the general wrongdoing rate keeps on staying at a 40-year low.

Colorado has likewise experienced comparative abatements in wrongdoing. Furthermore, the Colorado has enhanced its primary concern, sparing cash on the diminished captures and movement fatalities.

While the legitimization of cannabis in Colorado, Washington, Oregon and Alaska are significant leaps forward for a conceivable government authorization, it is still too soon to refer to the encounters of these states to bolster national medication arrangement choices.

Marijuana Stocks to buy in the Summer of 2021

Marijuana Stocks

Marijuana stocks have started getting main stream attention. You can see “experts” on TV talking about them on their financial news stations. Is it all just hype? The truth is many marijuana penny stocks are scams or desperate companies who lack the proper funding to ever compete with the big boys. It is already 2021and we still have people that wonder if there are any legit pot stocks.

Over the last five years, marijuana stocks have seen enormous growth. Every year more legislation is being passed giving people access to both medical and recreational use of Marijuana and Cannabis related products. The medical marijuana industry is expected to reach over 55 billion by 2025 some experts are estimating that California will add an addition 5 billion to its economy because of their decision to legalize the recreational use of the plant. By 2025 it is estimated that the weed industry will create an additional 500,000 jobs. There will be a lot of money made in marijuana stocks. There will also be a lot of money lost if you choose the wrong company at the wrong time.

As I am sure you can imagine smart investors are looking to take advantage of the future explosion in the industry. Our focus is to stay ahead of the game and be able to provide our subscribers with the most current and relevant Cannabis news as well as top-notch marijuana stocks alerts! First here are two stocks we are currently watching.

Top 3 marijuana penny  Stocks to buy in Summer of 2021

Ticker Symbol: CPWY

Clean Energy Pathways Inc. Seems to go on big runs this time of a year. Last year in February and March it ran over 1,000%. This is an under the radar low float stock that everyone will be talking about soon. We believe it will get pumped up soon and have a nice run.

Ticker Symbol: AVXL

The Anavex Life Sciences Corp. (AVXL) stock is getting a boost from company news and technical signals on the charts. The company has been granted a new treatment patent for Alzheimer’s disease. This patent is for the long term and could remain valid until 2037. Stock markets love this kind of news of any long-term success. That is why the AVXL stock is also getting much attention from traders and investors. This is another stock that you might like to include in your portfolio and buy it near the technical support levels, when the stock moves up with higher volumes. It looks like a good buy under $2.50 for a sell around $2.85.

Ticker Symbol: CGC Canopy Growth Corp.

CGC hit a 52 week low and has seemed to bounce. This is a stock we expect to do well over the next year leading into the 2020 election. This is a stock that is fun to trade options on. Last April I was a week early on my short. I shorted the CGC at 48 and made the mistake of not buying my option puts far enough out. The end result was a loss of 60k as the stock went to $51 a share. The timing was a week off. The stock fell from $51 to $13 a share and would have made millions instead of losing 60k on it.

Disclaimer: Our Affiliates and us own shares of CPWY and We plan to swing trade the stock for a profit. We have a bias and Everything written here is just for entertainment purposes please make your own buying and selling decisions. Any stocks mentioned on our penny stocks watchlist are our own opinion and are not investment advice. We are not registered brokers. 

Some of the most frequently asked questions we get are:

What are the best marijuana stocks to buy in for 2020?

Because the marijuana industry is still a relatively new industry some of the best marijuana stocks to buy are new companies that haven’t hit the mainstream newswires yet. This is good for you because it allows you to purchase these stocks before the crowd for a cheap price per a share. Our newsletter and text alerts are specifically in place to help get the word out on these new companies. Make sure you sign up so you can stay ahead of the average investor. The Majority of Weed stocks move on hype. Follow the hype and take profits.

What have been the top marijuana penny stocks in the sector the last several years?

There have been some stocks that have seen major growth over the last few years. Some of the most popular stocks have been MJNA, POTN, CANV, VAPE,GWPH,CANN, and TRTC. Some of the more popular ones lately are TLRY,CGC,NBEV,CRON. If you look below you will see more stocks listed.

Are weed stocks something good to buy now and hold long term?

That depends on what investment strategy fits you. Some people like buying penny stocks to swing trade and others are looking more for long-term holds. Find out which investment style fits you best.

Are both Hemp stocks and Cannabis stocks worth looking at?

The legalization of Cannabis for recreational use will also lift restrictions when it comes to hemp related products. Hemp was a ton of different uses. So savvy investors will be looking to make money in both the hemp and marijuana market.

Will marijuana companies have to use a crypto-currency like bitcoin?

There has been some speculation that companies will use cryptocurrency similar to bitcoin in order to accept payments for their products. Since state laws don’t necessarily match federal laws this is a precaution a lot of companies may take.

Where can I find an updated watchlist for marijuana stocks?

We provide our email and text subscribers with updated watchlist and alerts, so they are never left in the dark.

Can I invest in Canadian marijuana stocks?

Some of the biggest stock gainers in the last few years have been Canadian marijuana stocks. Most popular brokers and trading platforms like Etrade, Scottrade, and TD Ameritrade allow you to trade Canadians stocks.

In Conclusion

There is a ton of excitement surrounding the industry. Pot Stocks should be a booming industry for a long time! Below we have some useful information that we will keep updating regularly. You can sign up for our email alerts by visiting our homepage. We specialize in penny stocks, oil stocks, solar stocks and bitcoin stocks.



Make sure you sign up for our free text stock alerts by texting “ateam” to 94253 with your mobile device.



The United States is starting to completely green! Every year more and more states are legalizing marijuana.

Marijuana stocks in United states

List of Pot Stocks doing business in California

 

2020 is expected to be a huge year for pot stocks, With it being an election year expect Marijuana Stocks to start running October and hitting highs the week coming into Nov.

List of marijuana penny stocks that either have done business in California or their business is currently in California. This list includes stocks that have mentioned Marijuana or Hemp related products. A lot of these are marijuana penny stocks so they may not be fully reporting. 

ACOL- Acology Inc
ADVT-  Advantis Corporation
AVOP- AV1 Group, Inc.
CBIS- Cannabis Science Inc.
CNBX-Cannabics Pharmaceuticals Inc.
EMBR- Embarr Downs, Inc.
EXMT- Anything Technologies Media Inc.
FFRMF- Future Farm Technologies Inc.
GRCU- Green Cures & Botanical Distribution Inc.
GRNH- GreenGro Technologies, Inc.
HPNN- Hop-on, Inc.
HSCC- Homeland Security Corp.
ICBU- IMD Companies, Inc.
IMTV- Imagination TV, Inc.
ITNS- ITonis, Inc.
KGET- Kleangas Energy Technologies, Inc.
KSHB- KUSH BOTTLES INC
LVVV- KUSH BOTTLES INC
MCIG- mCig, Inc.
MCOA- Marijuana Company of America, Inc.
MJNA-Medical Marijuana, Inc.
MYDX- MyDx, Inc.
MYHI- Mountain High Acquisitions Corp.
NMUS- Nemus Bioscience, Inc.
PNTV- Players Network (THE)
PURA- Puration Inc.
RIGH- RightSmile, Inc.
SGDH-SGD Holdings, Ltd.
SGMD- Sugarmade, Inc.
SIPC-Sipp Industries, Inc.
TGIFF- Friday Night Inc.
TRTC- Terra Tech Corp.
USEI- US Energy Initiatives Corporation, Inc.
VAPE- Vape Holdings, Inc.
VAPI- Vapir Enterprises Inc.
VAPR- VaporBrands International, Inc.
VDRM- ViaDerma, Inc.
VTMB- Vitamin Blue Inc
WDRP- Wanderport Corp
WTCG- W Technologies, Inc.
XSNX- XsunX, Inc.
XTRM- Extreme Biodiesel, Inc.


List of Marijuana Stocks doing business in Canada

2020 figures also to be a very hot market for marijuana stocks in Canada. So we have put together a list of some of the Marijuana stocks that are located there.

ABcann Global (TSXV:ABCN) OTC #ABCCF

Alliance Growers (CSE:ACG) OTC #ALGWF

Aphria (TSX:APH) OTC #APHQF

Aurora Cannabis (TSX:ACB) OTC #ACBFF

Canadian Bioceutical (CSE:BCC) OTC #CBICF

Cannabix Technologies (CSE:BLO) OTC #BLOCF

CanniMed Therapeutics (TSX:CMED) OTC #CMMDF

CannTrust (CSE:TRST) no OTC found

Canopy Growth (TSX:WEED)  CGC

Cronos Group (TSXV:MJN) CRON

DOJA Cannabis (CSE:DOJA) OTC #DJACF

Tilray – TLRY

Emerald Health Botanicals (TSXV:EMH) OTC #TBQBF

Emblem (TSXV:EMC) OTC #EMMBF

Friday Night (CSE:TGIF) OTC #VPGDF

Future Farm Technologies (CSE:FFT) OTC #FFRMF

Global Cannabis Application (CSE:APP) OTC #FUAPF

Global Hemp (CSE:GHG) OTC #GBHPF

Golden Leaf Holdings (CSE:GLH) OTC #GLDFF

Harvest One Cannabis (TSXV:HVST) OTC #HVST

High Hampton Holdings (CSE:HC) no OTC found

iAnthus (CSE:IAN) OTC #ITHUF

InMed Pharmaceuticals (CSE:IN) OTC #IMLFF

International Cannabis (TSXV:ICC) OTC #ICCLF

Isodiol International (CSE:ISOL) OTC #ISOLF

Lexaria Bioscience (CSE:LXX) OTC #LXRP

Lotus Ventures (CSE:J) no OTC found

Liberty Health Sciences (CSE:LHS) OTC #LHSIF

Liberty Leaf (CSE:LIB) OTC #LIBFF

Marapharm Ventures (CSE:MDM) OTC #MRPHF

Maricann (CSE:MARI) OTC #MRRCF

Matica Enterprises (CSE:MMJ) LOTC #MQPXF

MedReleaf (TSX:LEAF) OTC #MEDFF

MYM Nutraceuticals (CSE:MYM) OTC #MYMMF

Naturally Splendid (TSXV:NSP) OTC #NSPDF

Newstrike (TSXV:HIP) no OTC found

Nutritional High (CSE:EAT) OTC #SPLIF

OrganiGram (TSXV:OGI) OTC #ORGMF

PUF Ventures (CSE:PUF) OTC #PUFXF

Quadron Capital Corporation (CSE:QCC) NO OTC found

Radient Technologies (TSXV:RTI) NO OTC found

Scythian Biosciences (TSXV:SCYB) OTC #SCCYF

Supreme Pharmaceuticals Inc. (CSE: SL) OTC #SPRWF

TerrAscend (CSE:TER) No OTC Found

Tetra Bio-Pharma (CSE:TBP) OTC #TBPMF

THC Biomed (CSE:THC) OTC #THCBF

Tinley Beverage (CSE:TNY) OTC #QRSRF

Valens GroWorks (CSE:VGW) OTC #MYMSF

Veritas Pharma (CSE:VRT) OTC #VRTHF

Vodis Pharmaceuticals (CSE:VP) OTC #VDQSF

WeedMD (TSXV:WMD) OTC #WDDMF

Wildflower Marijuana (CSE:SUN) OTC #WLDMF


Marijuana Penny Stocks

Marijuana penny stocks are companies that are still start up level companies. Most marijuana penny stock companies still rely on unorthodox financing. That means they are subject to a lot of pump and dumps.

Abattis Bioceuticals Corp. (ATTBF)

Aero Grow International Inc. (OTCMKTS:AERO)

Blue Line Protection Group (BLPG)

Cannabis Sativa Inc. (CBDS)

CannaGrow Holdings Inc (OTCMKTS:CGRW)

Cara Therapeutics (NASDAQ:CARA)

CGrowth Capital Inc (OTCMKTS:CGRA)

DigiPath, Inc (OTCMKTS:DIGP)

Electronic Cigarette International (ECIG)

Endexx (EDXC)

Full Circle Capital Corp (NASDAQ:FULL)

General Cannabis (OTCQB:CANN)

GreenGro Technologies Inc (OTCMKTS:GRNH)

Grow Condos, Inc. (OTCQB:GRWC )

Growblox Sciences Inc (OTCMKTS:GBLX)

GW Pharmaceuticals is a Hot Stock to Own with Several Bullish products

Hemp Inc (OTCMKTS:HEMP)

Indoor Harvest Corp, (INQD)

INSYS Therapeutics, Inc.

Lexaria Bioscience Corp. (LXRP)

Marijuana Industry is Risky, Traders are looking to Profit from Investments

Headquartered in Henderson, Nevada, mCig Inc. (OTCQB:MCIG)

Medicine Man Technologies (MDCL)

Mettrum Health Corp is on the Verge of Rebound

Plandai Biotechnology Inc (OTCMKTS:PLPL)

Rocky Mountain High Brands, Inc (OTCMKTS:RMHB)

Scotts Miracle-Gro Co. (NYSE:SMG)

Surna Inc (OTCMKTS:SRNA)

Terra Tech Corp (OTCMKTS:TRTC) is Set for Big Profits

The Future of the Marijuana Industry

Tweed Inc. (Tweed), wholly owned subsidiary of Canopy Growth

Corporation (Canopy Growth) (TSX: CGC) (OTC: TWMJF)

Two Rivers Water & Farming (OTCQB:TURV)

United Cannabis Corp. (OTCBB:CNAB)

Vapir Enterprises Inc. ( OTCQB:VAPI)

VPR Brands Continues to Grow

Zynerba Pharmaceuticals has Further Upside

Agree Realty $ADC

Alternaturals Inc. $ANAS

American Green Inc. $ERBB

Arena Pharmaceuticals $ARNA

Cannabics Pharmaceuticals $CNBX

Cannabis Capital $CBCA

Cannabis Science Inc (OTCMKTS:CBIS)
Cannabis-Rx, Inc. (OTCBB CANA)
Easton Pharmaceuticals Inc (OTCMKTS EAPH)
Inergetics Inc (OTCMKTS:NRTI)
Latteno Food Corp. (LATF)
Lexaria Bioscience Corp (OTCMKTS: LXRP)
Medican Enterprises Inc (OTCMKTS: MDCN)
Medicinal Marijuana, Inc. (OTCPK:MJNA)
MENTOR CAPITAL INC COM NPV (OTCMKTS:MNTR)
MMRGlobal, Inc., (MMRF)
Northsight Capital, Inc. (OTCBB NCAP)
Notis Global Inc (OTCMKTS:NGBL)
NOVUS ACQ and DEV (OTCMKTS:NDEV)
Puget Technologies, Inc. (OTC PUGE)
Sipp Industries (SIPC)
Stevia Corp (OTCMKTS:STEV)
Vapor Corp. (OTC:VPCO)
Vapor Group (VPOR)
VAPR’s (VAPR)

How to invest in marijuana stocks?

Marijuana stocks are the best way to get started for a penny stock investor. If you have not invested in penny stocks till date, this could be a great opportunity for you to explore. Marijuana stocks are super-hot stocks right now. The growth of legalized pot in various states of the US and Canada for medical and recreational use has led the investors to focus on the stocks.

If you’re interested to invest in marijuana penny stocks but don’t know the right way to begin, here is the full information about them. This sector is in trend right now due to legalization of pot in various forms. Some projects are new but require market capitalization to increase the annual marijuana stocks towards a much higher level. The marijuana market is expected to grow up to $150 billion or more after a decade, or so. As the sector is hot, the stocks could be hard to handle at times. The investors new to the marijuana world need to know what all to look and what to ignore while buying these stocks.

Marijuana Industry Basics

Marijuana have always been in trend for recreational purposes as a drug. In the present time, there are medications formulated by the use of marijuana and these trends have made it as a baseline for the stocks to grow. The dynamics are changing on the rapid basis and medical marijuana has become legalized in 30+ countries on global basis. The trend of recreational basis is common only in a few nations but the US and Canadian permissions have given a hint for the number to grow. Hemp was legalized at the national level in many US states in December 2018.

Tetrahydrocannabinol (THC) is the primary chemical responsible for causing the ‘high factor’ for the consumers. The chemical ingredient cannabinol (CBD) is not as psychoactive as THC and have been quite useful in the medical researches to control the problems like epilepsy, insomnia, and inflammation.

There are many products made from marijuana, like CBD oils, edibles, concentrates used in creams, lotions and vaping, beverages, flower, and many other forms. The marijuana industry stocks are involved in manufacturing and marketing of these products.

Investing in marijuana stocks

After getting the basics about marijuana industry, it is important to note the important elements of the industry. There are majorly three types of companies which could be considered in the investment of marijuana stocks:

  1. Marijuana growing companies: These companies are associated with the cultivation of marijuana in the indoor facilities and the greenhouses.
  2. Providers of ancillary products and services: These companies provide key services or products to the marijuana industry, like lighting systems, packaging, distribution, consultation, hydroponics etc.
  3. Biotech and Pharmaceutical companies: There are companies taking the medical use of marijuana for its benefit in the therapeutic industry. The medical use of marijuana is carried forward by many companies all over the globe and drugs are being manufactured for the treatment of chronic diseases.

How to grab the best marijuana stocks 2020?

Marijuana sector is a high-scope segment at this point because it has many associated companies that have given a huge contribution to the cannabis sector. There are some things to look while making the choice for the best marijuana stocks which can fetch a good amount for you.

  1. Decide the marijuana stocks to grab today

Unfortunately, there is no source which can guarantee you to buy the particular weed stocks at the moment. It is entirely up to you to look for the amazing stock options available on the web under $1 value. Make emphasis on the volatility of the stock and if there is no variation in the pricing, it means that the profit potential of the stock is on the lower side. You can also look for the high-volume stocks as the greater number of stocks traded every day will lead to better returns for the investors in the long run. You can control your losses only if you’re able to buy and sell the stocks quickly.

  • Use chart patterns and technical analysis for finding the best chances

Technical analysis is available for every stock on the web. It is the responsibility of the investor to make the stock trade research with carefulness to put your cash at risk. Stocks are all in the charts and the investors need to make sure that they’re fully researching them with due diligence to make the appropriate returns. It is always preferable to check out the clean chart patterns to make the diligent move and get greater odds of success. Your idea about volumes, price variations, and exciting news will make the things simpler for you to think and execute. Marijuana stocks might show a sudden boom in recent times but make sure that you’re making the right move to fetch the promising results.

  • Fundamental analysis for marijuana penny stocks

Marijuana penny stocks don’t have the strongest fundamentals and there are many untrue companies giving fake news and results showing developments. Make sure that the information you’re getting about the stock is from a good source. The company’s announcements regarding new contracts, subsidiary ownership, regulatory issues, and financing are done to increase your odds of success.

  • Grab hot stocks and gain profits

There is no use of buying a marijuana stock when there are no people discussing it. If nobody notices the stock, there will be simply no chance to gain profits from it. Make sure that you’re getting the hot stocks and people should talk about it for the big moves. It is important to buy and sell stocks at the right time. Checking out the right time is important than becoming greedy and selling off the stocks really late. The hype won’t last for eternity and this is the reality of stocks. Once you sell it at a profit, there is no use of checking the prices and repenting that you should have sold it later at a relatively higher price. Whenever you’re getting profits, remain contented and move ahead with a strong investment.

  • Create your own list of stocks

Keep the stock list ready to view on your mobile or laptop application. It is the way to take immediate advantage and a potential victory.

How to grab the best marijuana stocks 2019?

Weed penny stocks

Weed penny stocks are becoming red-hot popular in the present US and Canadian stocks. This herb has revolutionized the trends and the legalization of cannabis has led to a wider scope for the stocks related to cannabis in any way. The trades will become more profitable with the weed boom linked with various industrial segments. There is a lot of action taking place in the penny stock industry on a regular basis and pump & dump is the major scam due to which it becomes difficult to trust these stocks. There are rapid profits attained from some penny stocks but those are one in hundreds and a clever analyzer could only find them from a bunch of marijuana stocks on different stock markets.

Weed market growth

There are many people expecting that marijuana stocks will become 200-300% higher in price within very less time. This is the reason for the weed market growth and the stocks are coming up with many startups. The legal marijuana industry is expected to surpass almost every segment which has created a boom in the stock market. California is considered to be the hub of the weed markets all over the US. Medical marijuana was legal in the state for years but at the beginning of 2018, CA made adult-use of weed legalized as well. The market is huge and the inclusion of cannabis in many new segments has given a space for the industry to grow on the global platform.

Canada has already made the recreational weed usage legal and it is indeed the first nation to legalize it on the national level. Weed companies will have the most promising future in the sense of giving a lucrative beginning on the stock markets. Keeping an eye on the Canadian and USA weed stocks would probably lead towards a positive future for the companies.

Benefits of penny pot stocks

You need to concentrate on the two most important things to make quick and trusted profits on the stock market.

  1. Pick up a weed segment having the massive potential for growth. Check out the market trends, government news and the particular opinions on the sectors of your choice.
  2. Find out small companies having the probable approach to give profitable results from the hot sector where you can apply can turn huge profits. Keeping an eye on the beginner companies for marijuana stocks is a great idea for the investors to double or triple their money within the least possible time.

Finding the best weed stocks

Weed penny stocks are hot but you need to find out the appropriate resources to fetch the correct information about these stocks. Firstly, focus on day trading stocks. Penny stocks would change their values very soon and you can get in and out of the stocks by remaining informed about the day trends, price changes and appropriate steps to follow. You can decide the stocks to buy and check out its movements from time to time. It is merely the job of the investor to view the stocks and read everything about them before actually finalizing the stock for purchase.

Canada Marijuana Stocks

Cannabis stocks in Canada are very lucrative investments for people in America. The powerful bull market trend is set to go much higher with the legalization of hemp in the major US sectors. The market forecasts are giving a green signal for the Canadian marijuana stocks and it is anticipated that the investors will double, triple or even quadruple their investments by associating with some of the largest growing weed companies.

The government of USA legalized cannabis in some states in the year 2018 for recreational use. This expansion in the US market has given a chance to many Canadian companies to produce their products (medicinal or other forms) for the US market to generate better revenues. The demand for cannabis has increased because of legalization in recreational and medicinal use. There are new concepts introduced every day which require cannabis in different forms. There are supportive services giving indirect services to the cannabis sector (real estate, software, payment methods, and other modes). There has been a global acceptance and legalization of cannabis over time in Canada and it has flourished many companies associated with the hemp sector in any way.

Cannabis Stocks Canada 2020

Canadian Cannabis stocks are ultra-bullish at present and the forecast for 2020 is highly progressive. In the US market, the forecast for the annual compounded growth rate is expected to be 28% of cannabis demand. The Canadian market has already got hundreds of companies dealing with marijuana in any way. It is important for the investors to get in the stocks fast and even plan out their exit plan with the purchasing to assure their success. Smart investors have already clubbed their stocks and invested their amounts in the right penny stocks to avoid any surprises later on.

There has to be a focus on outperforming cannabis stocks in Canada. North American indexes are quite convincing in the present times and the cannabis stocks are expected to outperform and even triple out their value in 2020. Those who have accumulated the stocks in 2019 will get higher benefits than the people planning to buy the stocks now. Smart investors pick out the blooming segment stocks and make their diversified portfolio. It is a better choice than going for ETF for investments. Decent research is required before picking up the stocks. There is absolutely no secret followed for the investments but the investors need to be aware of what they are purchasing and WHY.

There are many Canadian marijuana stocks having a position on the major stock exchanges and some of them are on the penny stock lists (OTCBB and pink sheets). There are some stocks like Aurora Cannabis, Organigram Holdings, Kush Bottles, etc. which have given a positive performance in the marijuana stock investments. It is important to identify the right stock and make a wise movement by analyzing it well. Penny stock investments are worth purchasing as the majority of the stocks belonging to the reputed companies are growing or will grow in the coming future.

Discovery Gold Corp (OTCMKTS: DCGD) Continues to look bullish

Discovery Gold Corp (OTCMKTS: DCGD) Continues to Show Bullish Bias

Among the cannabis stocks, Discovery Gold Corp (OTCMKTS: DCGD) is continuing with a bullish bias and is showing comparatively more strength. After a slightly turbulent summer, with some controversial news reports, the company has now restructured its board of directors and added a cannabis industry expert, Vicki Christophersen, in the role of a strategic advisor.

Discovery Gold Corporation (OTC PINK: DCGD) is headquartered out of Seattle, Washington.  It is a rapidly expanding, publicly traded entity that has recently started emerging in the cannabis market.

The company has a market cap of $242.28M. Its share outstanding is 249.78M while the number of public floats is110.78M. The company has no current liabilities and is at is pre-revenue period for the time being.

In the last one month, Discovery Gold Corp (OTCMKTS: DCGD) has shown a growth of 19.02%. The stock has jumped 154.67% in the last 3 months. On a YTD basis, it has made a whopping gain of 22,458.14%.  In the last year, the stock has gone up by 17,536.36%. That is a very impressive growth cycle and the bullish bias seems to be continuing for this stock nonstop for the last one year. Add to that the restructuring moves and adding new talent to the company board, and we have a stock which is making headlines in the media, making waves in the markets and attracting the attention of traders and investors alike.

The company’s new strategy advisor, Vicki Christophersen is a well-known name within the cannabis and hemp industry. She has been an active champion for the industry in Washington state for many years now. She has also been government relations professional and has served at the Washington Canada business association for the last 6 years. She brings a wealth of subject expertise and regulatory knowledge to the company’s board and her presence will definitely provide more credence to the company’s business.

The company also announced that another expert, this time from the venture and financing industry, Justin Costello will also be joining as a strategic advisor. His domain expertise is finance-related so he will help the company with partnerships strategic planning and future investment in the quickly expanding cannabis industry. The company clarified that it has an aggressive growth plan and so having Mr. Costello on the advisory board will help it meet the growth targets.

In the last few weeks, the stock has been trading sideways and has been moving in a small narrow range. But it looks more like lethargy after hitting its all-time high price of more than $2 per share. While trading range-bound, the stock is still keeping above the technical indicator of 50 Day Simple Moving Average. This confirms the bullish bias in the stock. Perhaps it is just consolidating and gathering strength before making another jump towards higher levels. From the cannabis industry, Discovery Gold Corp (OTCMKTS: DCGD) stock looks quite promising and 2020 will be an interesting year to watch out for this stock.

 

Disclaimer: The author of this article does not own shares of DCGD.

This article is published by awesomepennystocks.com . The content included in this article is just for informational purposes only. Awesomepennystocks.com takes sensible consideration to ensure that the data given in this article is up to date and accurate. The news, prices, opinions, research, analysis, and other information published in this article are obtained from sources believed to be reliable.

Neither Awesomepennystocks.com nor any of Awesomepennystocks.com partners make any representation or guarantee as to the fulfillment or precision of the information contained in this article.

Investors must consult their own additional due diligence with any potential investment or highlighted company before making any decision on behalf of information offered by Stocksnewswire.com.

Information contained in this article may contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long-term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.

IS Canopy Growth Corp (CVE: CGC) a scam?

Canopy Growth

Meta description: Canopy Growth, in terms of market capitalization, is the largest cannabis company in the world. The company has developed a far-reaching base of subsidiaries through which it manufactures its products. It is based in Smith Falls, Ontario, Canada.

Company Background

Canopy Growth is a Canadian cannabis company based in Smith Falls, Ontario. It was initially co-founded in 2013 by Chuck Rifici, the acclaimed godfather of Canadian weed, and Bruce Linton as Tweed Marijuana Inc. The company is publicly traded on the New York Stock Exchange (NYSE) and the Toronto Stock Exchange (TSX), under the ticker symbols CGC and WEED respectively.

In 2015, it changed its name to Canopy Growth. Earlier in April 2014, it had become the first publicly traded North American company by listing on the Toronto Stock Exchange. In May 2018, it listed on the New York Stock Exchange, thereby becoming the first cannabis-producing company to do so. Today, Canopy Growth is the largest cannabis company in the world in terms of market capitalization.

The company’s vision to become the number one cannabis company in the world seems not to be a ruse. It really appears to be committed to it. It has extensive financing services, cutting-edge research and development, and manufacturing arms. Moreover, it has been able to develop medical and recreational cannabis brands with an attractive appeal to various members of the industry.

Industry Overview

The cannabis industry is currently the fastest-growing industry in the world. In fact, some analysts project that global cannabis annual sales will hit as much as $75 billion by 2030. The industry delivered $6.9 billion in global sales in 2016. Worldwide revenue significantly rose to $9.5 billion and $12.2 billion n 2017 and 2018 respectively.

Interestingly, analysts believe that this figure will further be racked up by full 2019 financial year. They have projected a global revenue increase of approximately 39%. This means that global cannabis sales can easily hit $16.9 billion and $31.3 billion by 2019 and 2022 respectively. Undoubtedly, the industry is poised for sustainable and rapid future growth.

Also, the business climate is becoming increasingly favourable for cannabis companies. Nine out of American states have legalised recreational cannabis use; medical use is already legal in 33. In 2018, Canada legalised recreational cannabis for adult use. Plus, the European market is opening up, too.

With access to finance, product diversity and differentiation, and strategic partnerships, a cannabis company has a decent chance of success.

Canopy Growth: In Vigorous Pursuit of Expansion

In 2016, Canopy Growth expanded its operations to Germany by acquiring the German-based pharmaceutical distributor, Medcann GmbH. For Canopy Growth, the German market was a fertile one. Germany depends solely on importation to satisfy its cannabis needs. This acquisition facilitated Canopy’s recognition as the first North American legal source of cannabis to Germany.

The same year, the company entered the Quebec cannabis market by acquiring Vert Médical. The strategic acquisition enhanced Canopy Growth’s growing facilities and product diversification. The company also went ahead to acquire majority ownership in another Quebec-owned cannabis firm, Groupe Hemp. Groupe Hemp is a fully Health Canada licensed hemp derivative producing and marketing company.

Currently, Canopy Growth’s Quebec market share is significant. The company accounts for approximately 30% of all medical cannabis supplied to registered patients within the province. The acquisitions of those Quebec-based firms helped to further diversify Canopy Growth’s product offerings.

In January 2017, Canopy Growth cemented its leading market position when it completed its acquisition of Mettrum Health. Mettrum Health is an Toronto-based company engaged in the research, production, and distribution of cannabis. The Mettrum deal significantly boosted Canopy’s production capacities and gave it more acreage for expansion.

In fact, the deal effectively made Canopy Growth the largest Cannabis company in Canada. Hence, subsequent to the deal, Canopy Growth’s licensed production facilities increased to six and its licensed production footprint grew to approximately 665,000 sq. ft.

In February 2018, the company and Sunniva entered into a strategic agreement. Sunniva is a North American supplier of medical cannabis products and services based in Calgary, Canada. The deal required Sunniva to supply Canopy Growth with 45,000 kilograms of high-quality medical cannabis products annually. It would be on for a two-year period starting from the first quarter of 2019.

Also, on May 22, 2019, the company announced its acquisition of the UK beauty brand, The Works, in a deal worth approximately $55 million. This deal would enable the company to develop new cannabis products for beauty, wellness, and sleep medical problems.

A Summary of Canopy Growth’s 2018 Production

For the last quarter of 2018, 33% of Canopy Growth’s net product revenue came from its oils including the Softgel capsules. This represented at least a 23% increase from the revenue the company generated from the same product class in the same period the previous year. The increase in revenue might not be a surprise because generally, value-added cannabis products and derivatives are high-margin products.

To position itself to meet its projected future demand for cannabis value-added products, the Company took steps to expand its extraction capacity. Consequently, it entered into extraction supply related agreements with Valens GroWorks Corp., Medipharm Labs Corp., and POS Holdings Inc. (“POS Holdings”).  In addition, the company has also inked an agreement with POS Holdings to acquire an exclusively dedicated extraction system.

Canopy Growth operates Tweed stores in Newfoundland and Manitoba and has a supply contract with all Canadian provinces. In addition, it currently has 10 licensed cannabis plants with a production capacity of more than 4.3 million square meters, including GMP-certified production areas of more than 500,000 square meters.

Financials

On June 30, 2108, Canopy Growth posted total revenue of $19.2 million for the second quarter. This represented an increase of approximately 14% from the previous quarter. Although the company posted a decline in revenue for the third quarter, its international medical revenues in the three months ended December 31, 2018, increased by 170%.

By the year ended December 31, 2018, the company also enjoyed a significant revenue from its wholly-owned subsidiary Storz & Bickel. Canopy Growth had completed its acquisition on December 6 of the year.

Summary

Is Canopy Growth a great stock to buy? Yes, but only if you are willing to assume a long-term approach. Apart from the fact that the cannabis industry will undoubtedly be huge, Canopy Growth is positioned to be a leader in it. Little wonder that Constellation Brands, the alcoholic beverage drink producer, increased its stake in it.

Canopy has the highest sales among marijuana producers. Its Canada’s market share for adult use of cannabis is also the largest. To hedge against domestic supply glut, the company has expanded to international markets. If all these could be sustained, Canopy is well positioned for tremendous future success, and so might be worth your buy.

 

Canopy Growth Is a Solid Marijuana Stock but currently overpriced

Marijuana stocks are likely to outperform this year, buoyed by seven U.S. states that have already legalized marijuana, while the other 10 states will discuss pot change in 2019. In addition, the Canadian authorities could authorize weed this year, as black market is estimated around $7 billion. Future fundamentals for marijuana stock also appears strong, thanks to the potential growth in legal marijuana demand.

CGC recently entered into a conditional deal with Acreage that is a head scratcher. They agreed to pay 3.6 billion for a company that only has a market cap of 935 million. Paying this huge premium doesn’t make a lot and right now the stock is being pumped up.

Marijuana sales are likely to increase by 178% to $20.6 billion by 2020, with a compound yearly development rate of 29%.
Canopy Growth Corp (CVE:CGC) is a diversified company, operating through its subsidiaries, including Tweed Inc., Tweed Farms Inc., and Bedrocan Canada Inc. The company has strong penetration in Canadian markets. It supplies pot to half of Canada’s present therapeutic cannabis base following the acquisition of Mettrum Ltd. The Canadian medicinal cannabis industry pulled in $869.0 million in lawful deals in 2016.
With the keen interest of Canadian Prime Minister, legal marijuana sales are anticipated to stand around $22.6 billion in the coming years. To place that into viewpoint, Canopy Growth is set to capitalize on growth opportunities.
This year, it altered its stock ticker to WEED, and continues to trade on the TSX. The company has a market capitalization almost $1.0 billion. Its revenue in the latest quarter increased 245% over the same period last year, while its revenue enlarged 22% sequentially to $8.5 million. It sold over one metric ton of marijuana in the latest quarter.
Moreover, the company has the potential to turn a strong revenue growth into big profits. Its net income was standing around $5.4 million, relative to earnings of $3.9 million over the prior year period. It also appears in a strong cash position to invest in growth opportunities, thanks to cash in hand of $45.5 million at the end of most recent quarter.